Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Macrophage Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Macrophage Therapeutics

Macrophage Therapeutics

MT develops precise immuno-oncology and anti-inflammatory therapeutics using a proprietary targeting platform.

HQ
Englewood Cliffs, NJ, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize immuno-oncology and anti-inflammatory treatments, Macrophage Therapeutics (MT) focuses on developing precise therapeutics using its proprietary Activated Macrophage targeting platform. The company leverages a unique CD206 receptor-based delivery system to enhance the precision and efficacy of proven therapeutic agents, significantly reducing off-target toxicity. MT aims to provide innovative solutions in the healthcare market, particularly in the fields of cancer and chronic inflammatory diseases.

Macrophage Therapeutics has attracted notable investors and industry experts due to its groundbreaking approach. The company's achievements include the development of therapeutics with binding affinities 10,000 times greater than current best-in-class antibodies, which has positioned MT as a leader in targeted therapy innovation. The impact of MT's work is evident in its potential to transform treatment paradigms, offering more effective and safer options for patients suffering from severe medical conditions.

Macrophage Therapeutics - Similar Companies

Thunder Biotech logo

Thunder Biotech

thunderbiotech.com

Sirpant Immunotherapeutics logo

Sirpant Immunotherapeutics

MacroGenics logo

MacroGenics

macrogenics.com

Macrotope logo

Macrotope

macrotope.com

Pheast Therapeutics logo

Pheast Therapeutics

pheast.com

Carisma Therapeutics logo

Carisma Therapeutics

carismatx.com

Piper Therapeutics logo

Piper Therapeutics

DEM Biopharma logo

DEM Biopharma

dembiopharma.com

Angarus Therapeutics logo

Angarus Therapeutics

angarustx.com

Marengo Therapeutics logo

Marengo Therapeutics

marengotx.com

Matchpoint Therapeutics logo

Matchpoint Therapeutics

matchpointtx.com

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Mechano-Therapeutics logo

Mechano-Therapeutics

Werewolf Therapeutics logo

Werewolf Therapeutics

werewolftx.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Macrophage Therapeutics - Quick Facts

Who are Macrophage Therapeutics' competitors?

Companies similar to Macrophage Therapeutics include Thunder Biotech, Sirpant Immunotherapeutics, MacroGenics and Macrotope.

When was Macrophage Therapeutics founded?

Macrophage Therapeutics was founded in 2015.

Where is Macrophage Therapeutics' headquarters located?

Macrophage Therapeutics' headquarters is located in Englewood Cliffs, NJ, US.

When was Macrophage Therapeutics' last funding round?

Macrophage Therapeutics' most recent funding round was for $2.5M (USD) in March 2015.

How much has Macrophage Therapeutics raised to-date?

As of Mar 13, 2015, Macrophage Therapeutics has raised a total of $2.5M (USD).

How many employees does Macrophage Therapeutics have?

Macrophage Therapeutics has 1 employee as of Feb 4, 2024.

Macrophage Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified